The Hippocratic vows that doctors took before dedicate their lives to the lofty cause of saving lives taught them to adhere to specific ethical standards. Unfortunately, many people are affected by large pharmaceutical companies, and large pharmaceutical companies may have conflicts of interest with medical practitioners because their main purpose of expanding their business is against doctor-treatment.
With the prevalence of opioids causing thousands of deaths year after year, collusion between the medical community and drug manufacturers is often attributed to it. Even for conditions that can be treated with alternatives, doctors are questioned for excessive use of opioid analgesics. A recent study at the Grayken Center at the Boston Medical Center found that doctors who received gifts and other in-kind benefits from pharmaceutical companies have opened up more opioids for patients.
The findings are very important because the government is facing increasing pressure to stop the crisis. Researchers recommend that drug manufacturers stop selling their products to doctors. They also believe that both the federal and state governments should consider limiting the amount of payments doctors receive from pharmaceutical companies.
Some important findings of the study are as follows:
-
The three companies associated with the clinic's most important payments are INSYS Therapeutics, T eva Pharmaceuticals, Janssen Pharmaceuticals. INSYS produces Subsys, a fentanyl-based product that appears as a sublingual spray. -
INSYS Therapeutics also accounts for 50% of non-research payments. The allowances that doctors receive for the promotion of opioids are free meals, holidays, presentations at seminars, etc. The company is currently undergoing a federal investigation accusing the sale of sprays to doctors and patients. A "fake" education plan. The company has a history of promoting drug abuse; a former employee has notified the company to engage in improper conduct, such as using a speaker program to force more doctors to prescribe their products, ideally, the product should only be used for cancer pain. The doctor wrote a $30 million opiate prescription for the subsidiary. -
In 2015, 369,139 doctors opened opioids under Medicare D. Last year, 25,767 [7%] of these doctors received 105,368 non-study funds related to opioids, amounting to more than $900 million. Non-study-related payments are associated with more opioid prescription practices, but researchers caution against linking causes and effects. -
Payments include 3,115 doctors' fees and/or honors over $6 million, 97,020 doctors' meals are close to $2 million, 1,862 medical expenses are $730,824, 360 doctors' consulting fees are $290,395, and $79,660 Education 3,011 doctors.
The opioid crisis is one of the most serious public health emergencies in the country's history. It directly or indirectly affects millions of people in the United States. In addition to prescription opioids, if abused, it is considered to be the number one public health hazard, and benzodiazepines and other prescription drugs are also part of the country's grim situation.
Any prescription drug, whether it is benzo, opioid, or even harmless cough syrup codeine, is associated with risk. Therefore, although the abuse of these drugs is not good, even using a prescription drug may not be harmful. For example, subsidiaries were found to have poor records, and since the approval of the US Food and Drug Administration [FDA], 63 people have been killed according to Agency estimates. Therefore, in terms of prescription drugs, it is best to ask the doctor about the consequences and ask if there are safer alternatives.
Orignal From: Research shows that doctors receive more opioid gifts from pharmaceutical companies
No comments:
Post a Comment